Charles W. Newhall III
Director at Supernus Pharmaceuticals · 7 reported transactions in 1 company · latest trade Oct 9, 2025
Their trades
Sold | Oct 9, 2025 | Oct 9, 2025 close $49.51 → Oct 23, 2026 close $40.70. S&P 500 +13.2% over the same days. | ||
Sold | Oct 9, 2025 | Oct 9, 2025 close $49.51 → Oct 23, 2026 close $40.70. S&P 500 +13.2% over the same days. | ||
Sold | Aug 27, 2025 | Aug 27, 2025 close $45.07 → Oct 23, 2026 close $40.70. S&P 500 +17.5% over the same days. | ||
Sold | Aug 25, 2025 | Aug 25, 2025 close $44.43 → Oct 23, 2026 close $40.70. S&P 500 +18.3% over the same days. | ||
Sold | Aug 22, 2025 | Aug 22, 2025 close $44.88 → Oct 23, 2026 close $40.70. S&P 500 +17.8% over the same days. |
$61.9K
Oct 9, 2025 close $49.51 → Oct 23, 2026 close $40.70. S&P 500 +13.2% over the same days.
$1.21M
Oct 9, 2025 close $49.51 → Oct 23, 2026 close $40.70. S&P 500 +13.2% over the same days.
$161.5K
Aug 27, 2025 close $45.07 → Oct 23, 2026 close $40.70. S&P 500 +17.5% over the same days.
$45K
Aug 25, 2025 close $44.43 → Oct 23, 2026 close $40.70. S&P 500 +18.3% over the same days.
$63.5K
Aug 22, 2025 close $44.88 → Oct 23, 2026 close $40.70. S&P 500 +17.8% over the same days.